Suppr超能文献

肥胖和饮酒协同作用增加肝细胞癌的风险:一项前瞻性队列研究。

Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.

机构信息

Division of Gastroenterology and Division of Epidemiology, University of California at San Diego, 9500 Gilman Drive, MC 0063, La Jolla, CA 92093, USA.

出版信息

Am J Epidemiol. 2013 Feb 15;177(4):333-42. doi: 10.1093/aje/kws252. Epub 2013 Jan 24.

Abstract

Obesity and alcohol interact to increase the risk of death from liver failure in men. In the present study, we aimed to examine whether obesity and alcohol were multiplicative or additive in increasing the risk of hepatocellular carcinoma (HCC) in both men and women. We conducted a prospective, population-based study of 23,712 Taiwanese residents (50.3% men) from 7 townships who underwent an evaluation for liver disease and were followed for 11.6 years for incident HCC. The mean age was 47 (standard deviation, 10) years and the mean body mass index (weight (kg)/height (m)(2)) was 24 (standard deviation, 3). Overall, 305 cases of HCC were identified over 275,126 person-years of follow-up. Age, male sex, alcohol drinking, cigarette smoking, elevated alanine aminotransferase, serum hepatitis B surface antigen, anti-hepatitis C virus positivity, and diabetes mellitus were each statistically significant predictors of incident HCC in univariate analyses (P < 0.05). Alcohol use and obesity (body mass index ≥30) showed a synergistic association with the risk of incident HCC in both unadjusted analyses (hazard ratio = 7.19, 95% confidence interval: 3.69, 14.00; P < 0.01) and multivariable-adjusted analyses (age, sex, smoking, serum alanine aminotransferase, serum hepatitis B surface antigen, anti-hepatitis C virus antibody, and diabetes mellitus) (hazard ratio = 3.82, 95% confidence interval: 1.94, 7.52; P < 0.01). Relative excess risks due to interaction, attributable proportion, and synergy index were 4.83, 0.67, and 4.53, respectively, suggesting a multiplicative interaction between alcohol use and obesity. Obesity and alcohol synergistically increase the risk of incident HCC.

摘要

肥胖和饮酒会增加男性因肝衰竭而死亡的风险。本研究旨在探讨肥胖和饮酒是否会对男性和女性的肝细胞癌(HCC)风险产生相加或相乘作用。我们进行了一项前瞻性、基于人群的研究,纳入了来自 7 个乡镇的 23712 名台湾居民(50.3%为男性),这些人接受了肝脏疾病评估,并随访了 11.6 年以发现 HCC 新发病例。平均年龄为 47(标准差为 10)岁,平均体重指数(体重(kg)/身高(m)(2))为 24(标准差为 3)。总的来说,在 275126 人年的随访中,共发现 305 例 HCC 病例。在单因素分析中,年龄、男性、饮酒、吸烟、丙氨酸氨基转移酶升高、乙型肝炎表面抗原阳性、抗丙型肝炎病毒阳性和糖尿病均为 HCC 新发病例的统计学显著预测因素(P < 0.05)。饮酒和肥胖(体重指数≥30)在未经调整的分析(危险比=7.19,95%置信区间:3.69,14.00;P < 0.01)和多变量调整分析(年龄、性别、吸烟、血清丙氨酸氨基转移酶、乙型肝炎表面抗原、抗丙型肝炎病毒抗体和糖尿病)中均与 HCC 新发病例风险呈协同关联(危险比=3.82,95%置信区间:1.94,7.52;P < 0.01)。交互作用所致的相对超额风险、归因比例和协同指数分别为 4.83、0.67 和 4.53,提示饮酒和肥胖之间存在相乘性交互作用。肥胖和饮酒协同增加 HCC 的发病风险。

相似文献

1
Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study.
Am J Epidemiol. 2013 Feb 15;177(4):333-42. doi: 10.1093/aje/kws252. Epub 2013 Jan 24.
2
Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men.
Clin Gastroenterol Hepatol. 2010 Oct;8(10):891-8, 898.e1-2. doi: 10.1016/j.cgh.2010.06.027. Epub 2010 Aug 17.
4
Natural history of chronic hepatitis B REVEALed.
J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x.
6
Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1636-45.e1-3. doi: 10.1016/j.cgh.2013.04.043. Epub 2013 May 10.
7
Hepatitis B e antigen and the risk of hepatocellular carcinoma.
N Engl J Med. 2002 Jul 18;347(3):168-74. doi: 10.1056/NEJMoa013215.
8
Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
J Natl Cancer Inst. 2004 Dec 15;96(24):1851-6. doi: 10.1093/jnci/djh334.
9
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
J Natl Cancer Inst. 2011 Nov 16;103(22):1686-95. doi: 10.1093/jnci/djr395. Epub 2011 Oct 21.
10
The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China.
Cancer Epidemiol Biomarkers Prev. 2019 Dec;28(12):2038-2046. doi: 10.1158/1055-9965.EPI-19-0303. Epub 2019 Sep 18.

引用本文的文献

1
RAB5 NUCLEOTIDE BINDING PROMOTES β-OXIDATION TO FUEL HEPATOCELLULAR CARCINOMA CELL PROLIFERATION.
bioRxiv. 2025 Aug 24:2025.08.20.670915. doi: 10.1101/2025.08.20.670915.
4
Cardiovascular Health Trajectories and Prevalent Metabolic Dysfunction-Associated Steatotic Liver Disease in Midlife: The CARDIA Study.
J Am Heart Assoc. 2025 Apr 15;14(8):e037948. doi: 10.1161/JAHA.124.037948. Epub 2025 Apr 7.
5
Update on the Complications and Management of Liver Cirrhosis.
Med Sci (Basel). 2025 Feb 5;13(1):13. doi: 10.3390/medsci13010013.
6
Impact of Weight Loss on Metabolic Dysfunction Associated Steatohepatitis and Hepatic Fibrosis.
Curr Diab Rep. 2025 Feb 18;25(1):23. doi: 10.1007/s11892-025-01579-1.
7
Impact of high body mass index on hepatocellular carcinoma risk in chronic liver disease: A population-based prospective cohort study.
PLoS One. 2025 Jan 22;20(1):e0316175. doi: 10.1371/journal.pone.0316175. eCollection 2025.
8
Alcohol and Hepatocellular Carcinoma.
Clin Liver Dis. 2024 Nov;28(4):633-646. doi: 10.1016/j.cld.2024.06.007. Epub 2024 Jul 23.
9
Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score.
JHEP Rep. 2024 Jun 3;6(10):101127. doi: 10.1016/j.jhepr.2024.101127. eCollection 2024 Oct.
10
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients.
Hepatol Int. 2024 Oct;18(Suppl 2):922-940. doi: 10.1007/s12072-024-10692-4. Epub 2024 Jul 16.

本文引用的文献

2
Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men.
Clin Gastroenterol Hepatol. 2010 Oct;8(10):891-8, 898.e1-2. doi: 10.1016/j.cgh.2010.06.027. Epub 2010 Aug 17.
6
Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas.
Gastroenterology. 2009 Apr;136(4):1134-44. doi: 10.1053/j.gastro.2009.02.038. Epub 2009 Feb 24.
7
Estimation of the relative excess risk due to interaction and associated confidence bounds.
Am J Epidemiol. 2009 Mar 15;169(6):756-60. doi: 10.1093/aje/kwn411. Epub 2009 Feb 11.
8
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
Gastroenterology. 2008 Jul;135(1):111-21. doi: 10.1053/j.gastro.2008.03.073. Epub 2008 Apr 4.
9
Hepatocellular carcinoma and sex.
N Engl J Med. 2007 Nov 8;357(19):1974-6. doi: 10.1056/NEJMcibr075652.
10
Long-term outcomes in hepatitis B: the REVEAL-HBV study.
Clin Liver Dis. 2007 Nov;11(4):797-816, viii. doi: 10.1016/j.cld.2007.08.005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验